Renee Gala named next CEO of Jazz Pharmaceuticals: Gala will take over as president and CEO on August 11, 2025, following ...

TPN-101, a potent nucleoside reverse transcriptase inhibitor that specifically inhibits the LINE-1 reverse transcriptase.

Marcel Botha discusses ways the agency can ensure it gets the most accurate results possible from AI.

The new doll will include an insulin pump, a glucose monitor, and a dress featuring international symbols for diabetes ...

Varda Space Industries announced its Series C fundraiser for medicine creation in space has reached $187 million. This now ...

One of the major complaints levied against FDA by the current administration is that the approval process is too complicated, takes too long, and needs to be modernized. The new leadership pledged to ...